2-230877483-G-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_030926.6(ITM2C):c.645G>T(p.Gly215Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00141 in 1,614,040 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0076 ( 18 hom., cov: 32)
Exomes 𝑓: 0.00076 ( 16 hom. )
Consequence
ITM2C
NM_030926.6 synonymous
NM_030926.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.423
Genes affected
ITM2C (HGNC:6175): (integral membrane protein 2C) Enables amyloid-beta binding activity. Involved in negative regulation of neuron projection development and neuron differentiation. Located in several cellular components, including Golgi apparatus; lysosome; and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 2-230877483-G-T is Benign according to our data. Variant chr2-230877483-G-T is described in ClinVar as [Benign]. Clinvar id is 775830.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.423 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00761 (1159/152332) while in subpopulation AFR AF= 0.0267 (1111/41566). AF 95% confidence interval is 0.0254. There are 18 homozygotes in gnomad4. There are 561 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 18 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITM2C | ENST00000326427.11 | c.645G>T | p.Gly215Gly | synonymous_variant | Exon 5 of 6 | 1 | NM_030926.6 | ENSP00000322730.6 | ||
ITM2C | ENST00000326407.10 | c.534G>T | p.Gly178Gly | synonymous_variant | Exon 4 of 5 | 1 | ENSP00000322100.6 | |||
ITM2C | ENST00000335005.10 | c.504G>T | p.Gly168Gly | synonymous_variant | Exon 4 of 5 | 1 | ENSP00000335121.6 | |||
ITM2C | ENST00000409704.6 | c.459G>T | p.Gly153Gly | synonymous_variant | Exon 5 of 6 | 5 | ENSP00000387242.2 |
Frequencies
GnomAD3 genomes AF: 0.00759 AC: 1155AN: 152214Hom.: 18 Cov.: 32
GnomAD3 genomes
AF:
AC:
1155
AN:
152214
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00185 AC: 464AN: 251358Hom.: 5 AF XY: 0.00142 AC XY: 193AN XY: 135890
GnomAD3 exomes
AF:
AC:
464
AN:
251358
Hom.:
AF XY:
AC XY:
193
AN XY:
135890
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000763 AC: 1116AN: 1461708Hom.: 16 Cov.: 33 AF XY: 0.000648 AC XY: 471AN XY: 727174
GnomAD4 exome
AF:
AC:
1116
AN:
1461708
Hom.:
Cov.:
33
AF XY:
AC XY:
471
AN XY:
727174
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00761 AC: 1159AN: 152332Hom.: 18 Cov.: 32 AF XY: 0.00753 AC XY: 561AN XY: 74500
GnomAD4 genome
AF:
AC:
1159
AN:
152332
Hom.:
Cov.:
32
AF XY:
AC XY:
561
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Dec 28, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at